Browse All

Current Filters

CLEAR FILTER x

TITLE

Baseline Serum Neurofilament Light Chain Levels Predict Future Disease Activity Irrespective of Race/Ethnicity: Results from the Phase 3 ASCLEPIOS I/II Trials

Author:Freeman, Jason   Delgado, Silvia   Alvarez, Enrique   Thouvenot, Eric   Okai, Annette   Bhatt, Alit   Wei, Wenjia   Ziemssen, Tjalf   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.006  

Author Institution:Novartis Pharmaceuticals, USCDMA , East Hanover , NJ  University of Miami Miller School of Medicine, Miami, FL  University of Colorado School of Medicine, Aurora, CO  CHU Nîmes, Univ Montpellier, Nîmes, France  North Texas Institute of Neurology and Headache, Plano, TX  Novartis Healthcare Pvt. Ltd., Hyderabad, India  Novartis Pharma AG, Basel, Switzerland  University Clinic Carl-Gustav Carus, Dresden, Germany